[HTML][HTML] Multimorbidity and serological response to SARS-CoV-2 nine months after 1st vaccine dose: European cohort of healthcare workers—Orchestra project

C Violán, LA Carrasco-Ribelles, G Collatuzzo, G Ditano… - Vaccines, 2023 - mdpi.com
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project

C Violán, LA Carrasco-Ribelles, G Collatuzzo… - …, 2023 - research.unipd.it
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers-Orchestra Project.

C Violán, LA Carrasco-Ribelles, G Collatuzzo, G Ditano… - Vaccines, 2023 - europepmc.org
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers-Orchestra Project.

C Violán, L Carrasco-Ribelles, G Collatuzzo, G Ditano… - VACCINES, 2023 - iris.univr.it
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers-Orchestra Project

C Violán, LA Carrasco-Ribelles, G Collatuzzo… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project.

C Violán, LA Carrasco-Ribelles, G Collatuzzo… - Vaccines, 2023 - search.ebscohost.com
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

[HTML][HTML] Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project

C Violán, LA Carrasco-Ribelles, G Collatuzzo, G Ditano… - Vaccines, 2023 - ncbi.nlm.nih.gov
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project

C Violán, LA Carrasco-Ribelles, G Collatuzzo… - Vaccines, 2023 - search.proquest.com
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers-Orchestra Project.

C Violán, LA Carrasco-Ribelles, G Collatuzzo, G Ditano… - Vaccines, 2023 - europepmc.org
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …